Decheng Capital Management III (Cayman), LLC, 10% Owner at ALPINE IMMUNE SCIENCES, INC. (ALPN), bought 3,085,106 shares at $9.40 ($29.0M) on 2021-09-17, disclosed to the SEC on 2021-09-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.40 | 1,542,553 | $14.5M | 50.0% |
| 2 | $9.40 | 1,542,553 | $14.5M | 50.0% |
| Total | $9.40 avg | 3,085,106 | $29.0M | 100% |
| Filing → |
| BYSI | SELL | 2025-09-11 | $41K | — | Filing → |
| BYSI | SELL | 2025-09-08 | $17K | — | Filing → |